Phase I, First-in-Human Study of the Probody Therapeutic CX-2029 in Adults with Advanced Solid Tumor MalignanciesMelissa L. Johnson, Alexander I. Spira, Navid Hafez et al.|Clinical Cancer Research|2021Cited by 61